Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: Preliminary results

References

• Non-small Cell Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized trials. Br Med J 1995; 311: 899–909
   PubMed Web of Science ®Google Scholar
• Bunn PA, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res 1998; 5: 1087–1100
   Google Scholar
• Jones EL, Samulski TV, Vujaskovic Z, Leonard RP, Dewhirst MW. Hyperthermia. Principles and Practice of Radiation Oncology4th, CA Perez, LW Brady, WC Halperin, RK Schmidt-Ullrich. Lippincott Williams & Wilkins, Philadelphia 2003; 699–735
   Google Scholar
• Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008; 24: 251–261
   PubMed Web of Science ®Google Scholar
• Xu MJ, Alberts DS. Potentiation of platinum analogue cytotoxicity by hyperthermia. Cancer Chemother Pharmacol 1988; 21: 191–196
   PubMed Web of Science ®Google Scholar
• Herman TS, Teicher BA, Chan V, Collins LS, Abrams MJ. Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes. Int J Radiat Oncol Biol Phys 1989; 16: 443–449
   PubMed Web of Science ®Google Scholar
• Othman T, Goto S, Lee JB, Taimura A, Matsumoto T, Kosaka M. Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel. Pharmacology 2001; 62: 208–212
   PubMed Web of Science ®Google Scholar
• Cividalli A, Cruciani G, Livdi E, Pasqualetti P, Tirindelli Danesi D. Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma. Int J Radiat Oncol Biol Phys 1999; 44: 407–412
   PubMed Web of Science ®Google Scholar
• Rietbroek RC, Katschinski DM, Reijers MH, Robins HI, Geerdink A, Tutsch K, d'Oleire F, Haveman J. Lack of thermal enhancement for taxanes in vitro. Int J Hyperthermia 1997; 13: 525–533
   PubMed Web of Science ®Google Scholar
• Mohamed F, Marchettini P, Stuart OA, Urano M, Sugarbaker PH. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol 2003; 10: 463–468
   PubMed Web of Science ®Google Scholar
• Zoul Z, Filip S, Melichar B, Dvorák J, Odrázka K, Petera J. Weekly paclitaxel combined with local hyperthermia in the therapy of breast cancer locally recurrent after mastectomy – A pilot experience. Onkologie 2004; 27: 385–388
   PubMedGoogle Scholar
• Kodama K, Doi O, Higashiyama M, Yokouchi H, Tatsuta M. Long-term results of postoperative intrathoracic chemo-thermotherapy for lung cancer with pleural dissemination. Cancer 1993; 72: 426–431
   PubMed Web of Science ®Google Scholar
• Alagoz T, Buller RE, Anderson B, Terrell KL, Squatrito RC, Niemann TH, Tatman DJ, Jebson P. Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 1995; 75: 2313–2322
   PubMed Web of Science ®Google Scholar
• Al-Waili NS, Butler GJ, Beale J, Hamilton RW, Lee BY, Lucas P. Hyperbaric oxygen and malignancies: A potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit 2005; 11: 279–289
   Web of Science ®Google Scholar
• Takiguchi N, Saito N, Nunomura M, Kouda K, Oda K, Furuyama N, Nakajima N. Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: Evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother Pharmacol 2001; 47: 11–14
   PubMed Web of Science ®Google Scholar
• Huang JL, Shao ZA, Yang AQ, Shi JM, Li FC, Guo ZW. Hyperbaric oxygen and antineoplastic drugs in the treatment of intermediate and advanced hepatic cancer. J Hyperbaric Med 1991; 6: 155–157
   Google Scholar
• Kawamura N, Matsunaga J, Tazaki H. Experience with massive anti-cancer chemotherapy under hyperbaric oxygen pressure in terminal urologic malignancy. Tokai J Exp Clin Med 1978; 3: 183–192
   Google Scholar
• Calvert AH, Newell DR, Gumbrell LA. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 17: 1748–1756
   Web of Science ®Google Scholar
• Schem BC, Dahl O. Thermal enhancement of ACNU and potentiation of thermochemotherapy with ACNU by hypertonic glucose in the BT4An rat glioma. J Neurooncol 1991; 10: 247–252
   PubMed Web of Science ®Google Scholar
• Song CW, Rhee JG, Lee CK, Levitt SH. Capacitive heating of phantom and human tumors with an 8MHz radiofrequency applicator (Thermotron RF-8). Int J Radiat Oncol Biol Phys 1986; 12: 365–372
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M. Radiofrequency capacitive hyperthermia for deep-seated tumors. I. Studies on thermometry. Cancer 1987; 60: 121–127
   PubMed Web of Science ®Google Scholar
• Hamazoe R, Maeta M, Murakami A, Yamashiro H, Kaibara N. Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep-seated tumors in the peritoneal cavity. J Surg Oncol 1991; 48: 176–179
   PubMed Web of Science ®Google Scholar
• Imada H. Development of new heating technique. Hyperthermia No Rinsho (in Japanese), T Matsuda, T Sugawara, M Abe, Y Tanaka. Iryokagaku, Tokyo 1999; 394–402
   Google Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
   PubMed Web of Science ®Google Scholar
• Feldmann HJ, Seegenschmiedt MH, Molls M. Hyperthermia – Its actual role in radiation oncology. Part III: Clinical rationale and results in deep seated tumors. Strahlenther Onkol 1995; 171: 251–264
   PubMedGoogle Scholar
• van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. The Kadota Fund International Forum 2004 – Clinical group consensus. Int J Hyperthermia 2008; 24: 111–122
   PubMed Web of Science ®Google Scholar
• Issels RD, Abdel-Rahman S, Wendtner C, Falk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: Long-term results of a phase II study. Eur J Cancer 2001; 37: 1599–1608
   PubMed Web of Science ®Google Scholar
• de Wit R, van der Zee J, van der Burg ME, Kruit WH, Logmans A, van Rhoon GC, Verweij J. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 1999; 80: 1387–1391
   PubMed Web of Science ®Google Scholar
• Westermann AM, Grosen EA, Katschinski DM, Jäger D, Rietbroek R, Schink JC, Tiggelaar CL, Jäger E, Zum Vörde sive Vörding P, Neuman A, et al. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. Eur J Cancer 2001; 37: 1111–1117
   PubMed Web of Science ®Google Scholar
• Belani CP, Barstis J, Perry MC, La Rocca RV, Nattam SR, Rinaldi D, Clark R, Mills GM. Multicenter, randomized trail for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation. J Clin Oncol 2003; 21: 2933–2939
   PubMed Web of Science ®Google Scholar
• Loesch D, Robert N, Asmar L, Gregurich MA, O'Rourke M, Dakhil S, Cox E. Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer. J Clin Oncol 2002; 20: 3857–3864
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ, Alvarez AA, Sayer RA, Lancaster JM, Soper JT, Berchuck A, Clarke-Pearson DL, Rodriguez GC, Carney ME. Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer. Gynecol Oncol 2003; 88: 51–57
   PubMed Web of Science ®Google Scholar
• Kallab AM, Nalamolu Y, Dainer PM, Jillella AP. A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer. Med Oncol 2005; 22: 145–151
   PubMed Web of Science ®Google Scholar
• Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (≥65 years of age): A phase II North Central Cancer Treatment Group study. Am J Clin Oncol 2003; 26: 441–447
   PubMed Web of Science ®Google Scholar
• Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92–98
   PubMed Web of Science ®Google Scholar
• Kelly K, Crowley J, Bunn PA, Jr, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A Southwest Oncology Group Trial. J Clin Oncol 2001; 19: 3210–3218
   PubMed Web of Science ®Google Scholar
• Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R, Berthet P, Breau JL, Lianes P, Nicholson M, et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: A cooperative multinational trial. Ann Oncol 2002; 13: 1539–1549
   PubMed Web of Science ®Google Scholar
• Itaya T, Yamaoto N, Ando M, Ebisawa M, Nakamura Y, Murakami H, Asai G, Endo M, Takahashi T. Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancer. Cancer Sci 2007; 98: 226–230
   PubMed Web of Science ®Google Scholar
• Kalns J, Krock L, Piepmeier E, Jr. The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res 1998; 18: 363–367
   PubMed Web of Science ®Google Scholar
• Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001; 155: 515–528
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Masunaga S, Nishimura Y, Nagata Y, Jo S, Akuta K, Li YP, Takahashi M, Abe M. Regional hyperthermia combined with radiotherapy in the treatment of lung cancers. Int J Radiat Oncol Biol Phys 1992; 22: 1009–1014
   PubMed Web of Science ®Google Scholar
• Karasawa K, Muta N, Nakagawa K, Hasezawa K, Terahara A, Onogi Y, Sakata K, Aoki Y, Sasaki Y, Akanuma A. Thermoradiotherapy in the treatment of locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1994; 30: 1171–1177
   PubMed Web of Science ®Google Scholar